These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39023688)

  • 1. Chitosan-enclosed SLN improved SV-induced hepatocellular cell carcinoma death by modulation of IQGAP gene expression, JNK, and HDAC activities.
    Harisa GI; Bakheit AH; Alshehri S; Attia SM; Attia MSM
    Mol Biol Rep; 2024 Jul; 51(1):824. PubMed ID: 39023688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IQGAP1 gene silencing induces apoptosis and decreases the invasive capacity of human hepatocellular carcinoma cells.
    Zoheir KM; Abd-Rabou AA; Harisa GI; Kumar A; Ahmad SF; Ansari MA; Abd-Allah AR
    Tumour Biol; 2016 Oct; 37(10):13927-13939. PubMed ID: 27488117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IQGAP1 and IQGAP2 are reciprocally altered in hepatocellular carcinoma.
    White CD; Khurana H; Gnatenko DV; Li Z; Odze RD; Sacks DB; Schmidt VA
    BMC Gastroenterol; 2010 Oct; 10():125. PubMed ID: 20977743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic Solid Lipid Nanoparticles of Resveratrol for Hepatocellular Carcinoma Treatment: Systematic Optimization, in vitro Characterization and Preclinical Investigation.
    Rahman M; Almalki WH; Afzal O; Alfawaz Altamimi AS; Kazmi I; Al-Abbasi FA; Choudhry H; Alenezi SK; Barkat MA; Beg S; Kumar V; Alhalmi A
    Int J Nanomedicine; 2020; 15():9283-9299. PubMed ID: 33262588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma.
    Wang LT; Chiou SS; Chai CY; Hsi E; Wang SN; Huang SK; Hsu SH
    Oncotarget; 2017 Jan; 8(5):7489-7501. PubMed ID: 27283490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive analysis of the expression and prognosis for IQ motif-containing GTPase-activating proteins in hepatocellular carcinoma.
    Dai Q; Song F; Li X; Huang F; Zhao H
    BMC Cancer; 2022 Nov; 22(1):1121. PubMed ID: 36320006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
    Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
    Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The up-regulation of histone deacetylase 8 promotes proliferation and inhibits apoptosis in hepatocellular carcinoma.
    Wu J; Du C; Lv Z; Ding C; Cheng J; Xie H; Zhou L; Zheng S
    Dig Dis Sci; 2013 Dec; 58(12):3545-53. PubMed ID: 24077923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase 6 functions as a tumor suppressor by activating c-Jun NH2-terminal kinase-mediated beclin 1-dependent autophagic cell death in liver cancer.
    Jung KH; Noh JH; Kim JK; Eun JW; Bae HJ; Chang YG; Kim MG; Park WS; Lee JY; Lee SY; Chu IS; Nam SW
    Hepatology; 2012 Aug; 56(2):644-57. PubMed ID: 22392728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Glycyrrhetinic Acid and Folate Modified Cantharidin Loaded Solid Lipid Nanoparticles for Targeting Hepatocellular Carcinoma.
    Xu Y; Wang M; Ning S; Yang Z; Zhou L; Xia X
    Molecules; 2022 Oct; 27(20):. PubMed ID: 36296377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polo-like Kinase 1-targeting Chitosan Nanoparticles Suppress the Progression of Hepatocellular Carcinoma.
    Wang D; Chang R; Wang G; Hu B; Qiang Y; Chen Z
    Anticancer Agents Med Chem; 2017; 17(7):948-954. PubMed ID: 27671301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes.
    Shin S; Kim M; Lee SJ; Park KS; Lee CH
    Cancer Genomics Proteomics; 2017; 14(5):349-362. PubMed ID: 28871002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic advancement of simvastatin-loaded solid lipid nanoparticles (SV-SLNs) in treatment of hyperlipidemia and attenuating hepatotoxicity, myopathy and apoptosis: Comprehensive study.
    Abo-Zalam HB; El-Denshary ES; Abdelsalam RM; Khalil IA; Khattab MM; Hamzawy MA
    Biomed Pharmacother; 2021 Jul; 139():111494. PubMed ID: 34243595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of IQGAPs and Ras families in an experimental mouse model for hepatocellular carcinoma: a mechanistic study of cancer progression.
    Zoheir KM; Abd-Rabou AA; Harisa GI; Ashour AE; Ahmad SF; Attia SM; Bakheet SA; Abdel-Hamied HE; Abd-Allah AR; Kumar A
    Int J Clin Exp Pathol; 2015; 8(8):8821-31. PubMed ID: 26464624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ID2-AS1 suppresses tumor metastasis by activating the HDAC8/ID2 pathway in hepatocellular carcinoma.
    Zhou Y; Huan L; Wu Y; Bao C; Chen B; Wang L; Huang S; Liang L; He X
    Cancer Lett; 2020 Jan; 469():399-409. PubMed ID: 31730902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
    Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
    Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent.
    Schmidt VA; Chiariello CS; Capilla E; Miller F; Bahou WF
    Mol Cell Biol; 2008 Mar; 28(5):1489-502. PubMed ID: 18180285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coupling HDAC4 with transcriptional factor MEF2D abrogates SPRY4-mediated suppression of ERK activation and elicits hepatocellular carcinoma drug resistance.
    Ma Q; Xu Q; Zhao J; Zhang W; Wang Q; Fang J; Lu Z; Liu J; Ma L
    Cancer Lett; 2021 Nov; 520():243-254. PubMed ID: 34339801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and Pharmacodynamic Evaluation of Resveratrol Loaded Cationic Liposomes for Targeting Hepatocellular Carcinoma.
    Jagwani S; Jalalpure S; Dhamecha D; Jadhav K; Bohara R
    ACS Biomater Sci Eng; 2020 Sep; 6(9):4969-4984. PubMed ID: 33455290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of hybrid-type modified chitosan derivative nanoparticles for the intracellular delivery of midkine-siRNA in hepatocellular carcinoma cells.
    Zhong J; Huang HL; Li J; Qian FC; Li LQ; Niu PP; Dai LC
    Hepatobiliary Pancreat Dis Int; 2015 Feb; 14(1):82-9. PubMed ID: 25655295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.